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Introduction
• Background
– Opioids have been reported to be overprescribed within otolaryngology [1]
– Prescribing practices within facial plastics and reconstructive surgery (FPRS) 
have also fallen culprit to the same patterns
– Literature demonstrates that patients do not consume as many pills as 
prescribed following FPRS procedures [2-4]
– Filling this medication peri-operatively correlates with persistent and 
prolonged use [5], potentially leading to opioid dependence
– The Surgeon General’s Report on Opioids stresses the need for alteration of 
post-operative pain regimen to manage pain but reduce unnecessary 
prescriptions [6,7]
• Rationale
– In light of the opioid epidemic, there is a need to alter current opioid 
prescribing practices following FPRS




– This study will investigate opioid prescription and 
subsequent consumption for functional and cosmetic 
FPRS procedures, with the aim of developing evidence-
based guidelines for postoperative pain management
• Research Question
– Can current opioid prescription practices following FPRS 
procedures be down-titrated without an increase in 
patient pain levels?
• Hypothesis
– Current prescription practices can likely be down-titrated 
without an increase in patient pain levels.
Approach
• Study design
– Prospective single center study
• Population / study sample
– Patients (n=72) who underwent FPRS procedures
• Septoplasty ± Functional Endoscopic Sinus Surgery (FESS), n=37
• Nasal Fracture Reduction ± Nasal Valve Repair, n=26
• Rhinoplasty, n=7
• Nasal valve repair only, n=2
• Outcome (dependent variable(s))
– Opioids consumed
• Data source and collection
– Epic
– Opioid usage, pain trends, and patient satisfaction were assessed using a paper questionnaire with 
a validated visual analog scale (VAS)
• Analysis 
– Utilize Microsoft Excel to calculate p-value differences for amount of opioids prescribed vs. opioids 
consumed
– Review Manager (RevMan) 5
Results
• Patients were prescribed an 
average of 47.6 morphine 
milligram equivalents (MME)
• Patients consumed on 
average 28.9 MME
– 38% unused (p < 0.05)
• VAS scoring (0-10) trended 
down from mean 5.5±2.8 at 
post-op day 0 to 1.7±1.9 at 
follow up visit























































– Imbalance of patients undergoing functional vs. cosmetic procedures (65 vs. 7)
– Variability in prescriptions provided
• Hydrocodone-acetaminophen, codeine-acetaminophen, oxycodone, oxycodone-
acetaminophen, tramadol
– Survey was limited to the first follow-up appointment
• Patients may have continued to experience pain and consume opioids afterward
• Conclusions
– Provided with our data from a single institution, we provide evidence towards 
decreasing current opioid prescriptions to better mitigate overprescription of opioids
Future Directions
• Larger-scale studies assessing opioid prescription and consumption for 
nasal procedures
• Investigation of MME prescription and consumption in other facets of 
FPRS procedures
• Development of educational materials to counsel patients on anticipated 
pain and nonnarcotic pain management
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